11.2.5—Vaccines

A vaccine introduces antigenic material deliberately to produce active artificial immunity. The material is chosen to stimulate a specific immune response without being intended to cause the disease.

1. Antigenic stimulation: Vaccine material presents antigens to the immune system. It may contain weakened whole pathogens, inactivated whole pathogens, or selected pathogen components such as proteins, sugars or toxoids.
2. Primary response: The antigens trigger a specific immune response, including plasma cells releasing antibodies against the vaccine antigen.
3. Memory formation: The response also forms memory cells. These cells preserve the antigen-specific information after the initial response has declined.
4. Later exposure: If the person encounters the same antigen again, memory cells help produce a faster and stronger secondary response, so antibodies can rise more rapidly and help control the pathogen before serious disease develops.

Vaccine antigen → primary antibody response → memory-cell formation → quicker, larger secondary response on re-exposure. This is active artificial immunity because the vaccinated person’s own immune system makes the response; the vaccine is not a direct infusion of ready-made antibodies.

A vaccine is not the same as passive antibody treatment, and protection is not an instant guarantee against every exposure. This card explains the immune principle and the safety distinction between vaccine material and disease-causing infection; population vaccination programmes belong to the next objective.